This inventor holds 4 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Incyte Corporation. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Claymont, DE (US) (2023)
- Wilmington, DE (US) (2023)
Company Filing History:
Years Active: 2023-2025
Title: The Innovative Contributions of Yu Bai
Introduction
Yu Bai is a prominent inventor based in Claymont, Delaware, known for his significant contributions to the field of pharmaceuticals. With a total of four patents to his name, Bai has made strides in developing compounds that target critical pathways in cancer treatment.
Latest Patents
Among his latest patents, Bai has developed tricyclic urea compounds that act as JAK2 V617F inhibitors. This application provides compounds that modulate the activity of the V617F variant of JAK2, which are useful in treating various diseases, including cancer. Another notable patent involves imidazopyridazine compounds, which are disclosed for their ability to inhibit ALK2 activity. These compounds are beneficial in treating, preventing, or ameliorating diseases associated with ALK2 activity, such as cancer.
Career Highlights
Yu Bai is currently associated with Incyte Corporation, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing novel therapeutic agents that address unmet medical needs.
Collaborations
Bai collaborates with talented individuals in his field, including Jun Pan and Liangxing Wu, who contribute to the advancement of their shared research goals.
Conclusion
Yu Bai's innovative work in developing targeted compounds for cancer treatment highlights his importance in the pharmaceutical industry. His contributions are paving the way for new therapeutic options that could significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile